PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3931905-1	1985	Enzymes of the pyrimidine base catabolism, dihydrouracil dehydrogenase (EC 1.3.1.2), dihydropyrimidinase (EC 3.5.2.2), and beta-ureidopropionase (EC 3.5.1.6) were compared in the cytosolic extract of several normal and neoplastic human tissues.	pyrimidine	15-25	beta-ureidopropionase 1	Homo sapiens	123-144	
35151535-1	2022	beta-Ureidopropionase is the third enzyme of the pyrimidine degradation pathway and catalyses the conversion of N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid to beta-alanine and beta-aminoisobutyric acid, ammonia and CO2.	pyrimidine	49-59	beta-ureidopropionase 1	Homo sapiens	0-21	
30608453-1	2019	beta-Ureidopropionase (betaUP) deficiency is an autosomal recessive disease caused by abnormal changes in the pyrimidine-degradation pathway.	pyrimidine	110-120	beta-ureidopropionase 1	Homo sapiens	0-21	
30608453-1	2019	beta-Ureidopropionase (betaUP) deficiency is an autosomal recessive disease caused by abnormal changes in the pyrimidine-degradation pathway.	pyrimidine	110-120	beta-ureidopropionase 1	Homo sapiens	23-29	
29976570-1	2018	beta-Ureidopropionase (betaUP) catalyzes the third step of the reductive pyrimidine catabolic pathway responsible for breakdown of uracil-, thymine- and pyrimidine-based antimetabolites such as 5-fluorouracil.	pyrimidine	73-83	beta-ureidopropionase 1	Homo sapiens	0-21	
29976570-1	2018	beta-Ureidopropionase (betaUP) catalyzes the third step of the reductive pyrimidine catabolic pathway responsible for breakdown of uracil-, thymine- and pyrimidine-based antimetabolites such as 5-fluorouracil.	pyrimidine	73-83	beta-ureidopropionase 1	Homo sapiens	23-29	
29976570-1	2018	beta-Ureidopropionase (betaUP) catalyzes the third step of the reductive pyrimidine catabolic pathway responsible for breakdown of uracil-, thymine- and pyrimidine-based antimetabolites such as 5-fluorouracil.	pyrimidine	153-163	beta-ureidopropionase 1	Homo sapiens	0-21	
29976570-1	2018	beta-Ureidopropionase (betaUP) catalyzes the third step of the reductive pyrimidine catabolic pathway responsible for breakdown of uracil-, thymine- and pyrimidine-based antimetabolites such as 5-fluorouracil.	pyrimidine	153-163	beta-ureidopropionase 1	Homo sapiens	23-29	
27553092-1	2017	beta-Ureidopropionase deficiency is a rare autosomal recessive disease affecting the last step of pyrimidine degradation, and it is caused by a mutation in the UPB1 gene.	pyrimidine	98-108	beta-ureidopropionase 1	Homo sapiens	0-21	
27553092-1	2017	beta-Ureidopropionase deficiency is a rare autosomal recessive disease affecting the last step of pyrimidine degradation, and it is caused by a mutation in the UPB1 gene.	pyrimidine	98-108	beta-ureidopropionase 1	Homo sapiens	160-164	
25445412-1	2015	BACKGROUND: Beta-ureidopropionase deficiency is a rare inborn error of metabolism (IEM) affecting pyrimidine metabolism.	pyrimidine	98-108	beta-ureidopropionase 1	Homo sapiens	12-33	
17065070-1	2006	beta-Ureidopropionase is the third enzyme of the pyrimidine degradation pathway and it catalyses the irreversible hydrolysis of N-carbamyl-ss-aminoisobutyric acid or N-carbamyl-ss-alanine to beta-aminoisobutyric acid or ss-alanine, ammonia, and CO2.	pyrimidine	49-59	beta-ureidopropionase 1	Homo sapiens	0-21	
24328561-1	2013	beta-Ureidopropionase is the third enzyme of the pyrimidine degradation pathway and it catalyzes the conversion of N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid to beta-alanine and beta-aminoisobutyric acid, respectively, and ammonia and CO2.	pyrimidine	49-59	beta-ureidopropionase 1	Homo sapiens	0-21	
25638458-1	2015	beta-Ureidopropionase deficiency (OMIM #613161) is a rare autosomal recessive inborn error of metabolism due to mutations in the UPB1 gene, which encodes the third enzyme involved in the pyrimidine degradation pathway.	pyrimidine	187-197	beta-ureidopropionase 1	Homo sapiens	0-21	
25638458-1	2015	beta-Ureidopropionase deficiency (OMIM #613161) is a rare autosomal recessive inborn error of metabolism due to mutations in the UPB1 gene, which encodes the third enzyme involved in the pyrimidine degradation pathway.	pyrimidine	187-197	beta-ureidopropionase 1	Homo sapiens	129-133	
24940676-2	2014	beta-Ureidopropionase is the third enzyme of the pyrimidine degradation pathway and it catalyzes the conversion of N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid to beta-alanine and beta-aminoisobutyric acid, respectively, and ammonia and CO2.	pyrimidine	49-59	beta-ureidopropionase 1	Homo sapiens	0-21	
15385443-1	2004	beta-Ureidopropionase deficiency is an inborn error of the pyrimidine degradation pathway, affecting the cleavage of N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid.	pyrimidine	59-69	beta-ureidopropionase 1	Homo sapiens	0-21	
7765578-9	1994	It has been suggested that D-amino acid production from DL-5-substituted hydantoin involves the action of a series of enzymes involved in pyrimidine degradation, namely amide-ring opening enzyme, dihydropyrimidinase, and N-carbamoylamide hydrolyzing enzyme, beta-ureidopropionase.	pyrimidine	138-148	beta-ureidopropionase 1	Homo sapiens	258-279	
11804209-5	2001	The deficiency of beta-ureidopropionase was confirmed by measuring all three enzymes of the pyrimidine degradation pathway.	pyrimidine	92-102	beta-ureidopropionase 1	Homo sapiens	18-39